MultiCell Technologies, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MultiCell Technologies, Inc.

MCET 0.000001000

-90.0%

Jun 6 1:41 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: jimpit who wrote (206)	9/2/2010 3:37:58 PM
From: Shawn Donahue	Read Replies (1) of 237

Thank you for the links Jim! Interesting and potentially valuable information given. I agree with you that securing those grants could make a big difference in funding the MCT-125 Phase 11b clinical trial in the U.K., and they already have hired Clinical Development & Support Services, Ltd. "to manage" this, so things look to be in place. From previous research, I could find no one else working on the treatment of MS-related fatigue! So this could be a large market opportunity. The patents granted this last year certainly add credibility, if not more value to this company. Then the other three MCT-series therapeutic antibody technologies with the potential to treat breast or liver cancer are certainly worthwhile and much needed pursuits, in my opinion. I need to better research the potential of selling "life science research products" with Maxim Biotech, Inc through an "E-commerce" site. Do you have ideas of anyone else currently doing this? Thanks again, Shawn

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next